Skip to main content
. Author manuscript; available in PMC: 2009 May 15.
Published in final edited form as: J Immunol. 2008 May 15;180(10):6490–6500. doi: 10.4049/jimmunol.180.10.6490

Table I.

Characteristics of participantsa

Characteristic LTNP CD4 > 500/μl VL Typical < 2000 Copies/ml > 10 Years No Therapy n = 20 PROG CD4 < 200/μl VL > 10,000 Copies/ml No Therapy n = 18 RESP CD4 > 500/μl, Previously < 200/μl VL Undetectable on Therapy n = 19
Median CD4 count, cells/μl (IQR) 770 (685 to 955) 55 (22 to 124) 703 (596 to 836)
Median CD8 count, cells/μl (IQR) 1146 (935 to 1693) 770 (424 to 973) 1088 (920 to 1476)
Median Plasma HIV RNA level, copies/ml (IQR) 114 (<75 to 1438) 65864 (36702 to 154765) <75
Median age, years (IQR) 48 (44 to 52) 45 (42 to 51) 49 (42 to 60)
Median year 1st HIV+ test (IQR) 1988 (1986 to 1990) 1990 (1986 to 1993) 1989 (1987 to 1992)
Ethnicity percentage B/AA, W/C, A, M, H/L, PI 50, 35, 5, 10, 0, 0 17, 44, 0, 6, 28, 6 21, 58, 5, 0, 11, 5
Female gender 25% 11.1% 21.1%
a

IQR, Interquartile range; B/AA, Black/African-American; W/C, White/Caucasian; A, Asian; M, Mixed; H/L, Hispanic/Latino; PI, Pacific Islander.